Allergic Conjunctivitis

WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2022, Laura M. Periman, MD, discusses allergic conjunctivitis, dry eye disease and the role of Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix).

The FDA has approved a supplemental new drug application for Dextenza, adding ocular itching associated with allergic conjunctivitis to the drug’s current indications, according to a press release from Ocular Therapeutix.

Quality of life for children with allergic conjunctivitis was significantly lower for them and their parents compared with children without it, according to findings published in JAMA Ophthalmology.

Maternal lifetime incidence of pollinosis and allergic conjunctivitis was observed as new predictive factors for infantile hemangioma, according to a letter in Journal of Investigative Dermatology.

Dextenza may relieve ocular itching in patients with allergic conjunctivitis for up to 4 weeks, according to a study published in American Journal of Ophthalmology.

Aldeyra Therapeutics has released positive topline results from a phase 3 clinical trial investigating reproxalap in patients with allergic conjunctivitis, according to a press release.

The Japanese Ministry of Health, Labour and Welfare approved Johnson & Johnson Vision’s Acuvue Theravision with Ketotifen, a drug-releasing combination contact lens designed for both vision correction and allergic eye itch relief.

The FDA has accepted a supplemental new drug application for Dextenza for the treatment of ocular itching associated with allergic conjunctivitis, according to a press release from Ocular Therapeutix.

Ocular Therapeutix has submitted a supplemental new drug application for Dextenza as a treatment for ocular itching associated with allergic conjunctivitis, according to a press release.

Season, study population and methods of examination can significantly influence incidence and prevalence estimates of allergic conjunctivitis, according to a presentation at the virtual American Academy of Ophthalmology annual meeting.